Dynamk Capital
Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies. We partner with life science visionaries whose market-defining ideas are shaping the future of how therapeutics are being developed, increasing access for patients, and reducing costs.
Founded 2017 · Venture Capital
New York (
United States)
United States)Investment Stages
Seed
Series A
Series B
Markets
Life Science Industrials
tools
technologies
services for the discovery
development and production of life-saving therapies
Portfolio Companies
Virica Biotech, Lucid Scientific, Alpenglow Biosciences, CellFE Biotech, Curibio, RoosterBio, Vectron Biosolutions, Vernal Biosciences, CellFE Biotech, Envisagenics, RESIPHER, Xcell Bioscience
Related VC firms in United States